TY - JOUR T1 - Bilateral intravitreal injection of antivascular endothelial growth factor therapy. JF - Retina (Philadelphia, Pa.) Y1 - 2011 A1 - Mahajan, Vinit B A1 - Elkins, Kori A A1 - Russell, Stephen R A1 - Boldt, H Culver A1 - Gehrs, Karen M A1 - Weingeist, Thomas A A1 - Stone, Edwin M A1 - Abràmoff, Michael D A1 - Liu, Dawei A1 - Folk, James C KW - Aged KW - Aged, 80 and over KW - Antibodies, Monoclonal KW - Case-Control Studies KW - Drug Administration Schedule KW - Drug Combinations KW - Female KW - Follow-Up Studies KW - Humans KW - Incidence KW - Injections, Intraocular KW - Macular Degeneration KW - Male KW - Middle Aged KW - Myocardial Infarction KW - Patient Preference KW - Retrospective Studies KW - Vascular Endothelial Growth Factor A KW - Vitreous Body AB -

The purpose of this study was to review adverse events and patient preference after bilateral intravitreal injection of antibodies to vascular endothelial growth factor.

VL - 31 IS - 1 U1 - http://www.ncbi.nlm.nih.gov/pubmed/21187731?dopt=Abstract ER -